New Delhi: The Centre on Tuesday (March 30, 2021) introduced that the 2 COVID-19 vaccines Covishield and Covaxin are effective against the UK and the Brazillian variants of the novel coronavirus. The authorities additionally knowledgeable that research have been being performed at a number of laboratories against the South African pressure.
In a weekly press convention by the Union well being ministry, ICMR Director-General Balram Bhargava stated 11,064 genome samples have been sequenced within the nation, the UK variant of the virus was detected in 807, the South African variant in 47 and the Brazilian variant was present in one.
“Both the vaccines – Covishield and Covaxin- are effective against the UK and the Brazillian variants and the work against the South African variant is ongoing at several laboratories,” he was quoted as saying by PTI.
Bhargava additional stated that mutations are sporadic and single mutations are usually not discovered to be dominant in any specific space in India.
“In terms of significance of the point of double mutations they are not significant as far as India is concerned and their relationship with increased severity or increased transmissibility has not been established in Indian context,” he stated.
Last week, the Union well being ministry stated the brand new “double mutant” variant of SARS-CoV-2 was detected in Delhi, Maharashtra and another locations along with the three “variants of concern” — first observed within the UK, South Africa and Brazil — which have been present in no less than 18 states and union territories.
